A team of researchers consisting of endocrinologists from Siberia State Medical University was acknowledged the best global team involved in type 2 diabetes clinical trials. At an international meeting of Global Study Symposium researchers in Rome the team was awarded a Golden Certificate.
Siberian State Medical University is one of th leading Russian clinical study sites. Its employees have already participated in over 150 international clinical studies at multidisciplinary clinics and clinical departments employing over 25 principle investigators with average professional background of over 20 years
The university is accredited to perform clinical trials of all phases (I-IV) and clinical trials of medical devices. It cooperates with leading Russian and International pharmaceutical companies and contract-research organizations (Worldwide Clinical Trials, JSC GlaxoSmithKline Trading, Pfizer, Janssen Pharmaceuticals, Merck Sharp and Dohme Idea Inc. (MSD), Novo-Nordisk LLC, Sanofi, Generium, Pharmstandard, Ufa Vita LLC etc.).
In 2015 SibSMU became the first Russian University accredited by Skolkovo Technopark to perform clinical studies and clinical testing of new methods of treatment.